Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

106.11 -0.03 (-0.03%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
A Look Into Boston Scientific Inc's Price Over Earnings
Via Benzinga
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming
Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock. 
Via Investor's Business Daily
Revolutionizing Breakthroughs in Cardiac Diagnosis and Treatment: Boston Scientific Corporation (NYSE: BSX) vs Catheter Precision (NYSEAMERICAN: VTAK)
Via AB Newswire
Exposures Product Safety
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
(BSX) - Analyzing Boston Scientific's Short Interest
Via Benzinga
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Medical Devices Provider Boston Scientific Cardiovascular Segment Sees Traction In Q3, Company Adjusts Annual Outlook
Boston Scientific Corp (NYSE: BSX) generated Q3 revenues of $3.53 billion, beating the Wall Street estimate of $3.48 billion. 
Via Benzinga
Boston Scientific Inches Closer To A Breakout After Eking Out A Third-Quarter Beat
The company also raised its outlook for the full year. 
Via Investor's Business Daily
Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem
Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in. 
Via Benzinga
Boston Scientific Unusual Options Activity For October 12
Via Benzinga
How Is The Market Feeling About Boston Scientific?
Via Benzinga
Here's How Much $100 Invested In Boston Scientific 15 Years Ago Would Be Worth Today
Via Benzinga
Good technical signals and a possible breakout for BOSTON SCIENTIFIC CORP.
NYSE:BSX Shows Potential for a Breakout. 
Via Chartmill
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
Via Talk Markets
Topics Economy
Exposures Economy
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises. 
Via Benzinga
Topics Stocks
Exposures US Equities
The Pros Got It Wrong: 3 Stocks to Sell Despite Recent Upgrades
These three stocks to sell may be good picks for nimble traders, but for long-term investors, it may be time to put them aside. 
Via InvestorPlace
7 Affordable Stocks to Invest in as America’s Population Ages
Stocks for an aging population include some surprisingly youthful products and firms not commonly associated with seniors. 
Via InvestorPlace
Jim Cramer Says 'Entertainment Stocks Are So Hated': Here's One That's 'Not Expensive Anymore'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Devon Energy Corporation’s (NYSE: DVN) stock is "low enough, it had a bad quarter, it’s being punished 
Via Benzinga
Stock Market Falls Into Correction On Hawkish Fed: Weekly Review
Treasury yields surged to long-term highs, while leading stocks buckled. 
Via Investor's Business Daily
What Is the Boston Scientific Foundation?
Via ACCESSWIRE
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
The Latest Analyst Ratings for Boston Scientific
Via Benzinga
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
Zoom Video, eBay And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by around 275 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Boston Scientific's 'Next Level' Long-Term Plans: Why 2 Analysts Boost Price Targets
Boston Scientific Corporation (NYSE: BSX) CEO Mike Mahoney set the theme at the company's 2023 Investor Day  
Via Benzinga
CrowdStrike Holdings To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Thursday
Needham increased the price target for CrowdStrike Holdings, Inc. (NASDAQ: CRWD) from $200 to $215. Needham analyst Alex Henderson maintained a Buy rating. CrowdStrike shares fell 1% to close at... 
Via Benzinga
Boston Scientific Briefly Launches Into Buy Zone, But Investor Day Hype Cools
The company is following up on acquisition plans announced Tuesday with its Investor Day. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.